PLA/PLGA Injectable Microspheres
Description: The Shanghai Institute of Planned Parenthood Research (SIPPR) is developing a long-acting, injectable PLA/PLGA microsphere formulation for delivery of LNG for up to 6 months.
Delivery Method: Injectable
Duration Type: Short-acting
Duration: 6 months
Active Pharmaceutical Ingredient (API):
Inactive material: PLA; PLGA
Multipurpose Preventive Technology (MPT): No
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Began discovery in: 2013
Active Development: Yes
- In vivo PK data in rats indicates 6-7 months release for select formulations.